Print ISSN:-2394-6784

Online ISSN:-2394-6792


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article view: 92

Article download: 79

Indian Journal of Pathology and Oncology

Ki67 labeling in CNS tumours

Full Text PDF Share on Facebook Share on Twitter

Author Details : Uttara Mani*, Manjiri Karandikar, Narayanan Subramanian Mani

Volume : 6, Issue : 4, Year : 2019

Article Page : 586-592

Suggest article by email


A study of Ki67 Labeling Index (LI) by immunohistochemistry was carried out in 47 CNS neoplasms.
Astrocytic and oligodendroglial tumours were the most common group with glioblastoma, NOS and diffuse
astrocytoma, NOS Grade II predominating. Ki67 LI of diffuse astrocytomas varied from 0.72 to 13.9% with
a mean of 4.36%. In glioblastomas the Ki67 LIs varied from 5.96 to 22.4% with a mean of 12.3% which
was comparable with various studies. 1 pleomorphic xanthoastrocytoma was reclassified as anaplastic type
based on a high LI of 21.66%. All histological variants of ependymomas showed uniformly low Ki67 LIs.
Grade I meningiomas show ed a mean Ki67 LI of 2.22% for benign, 5.85% for atypical Grade II and 30%
in the anaplastic Grade III meningioma. Choroid plexus carcinoma and Non Hodgkins lymphomas showed
very Ki67 LIs from 60 to 91%. The findings correlated well with WHO CNS tumour grade and helped to
identify histologically defined lower grade tumours with potential for recurrence and progression.

Keywords: CNS neoplasms, Gliomas, Proliferation markers, Ki67.

Doi : 10.18231/j.ijpo.2019.114

How to cite : Mani U, Karandikar M, Mani N S, Ki67 labeling in CNS tumours. Indian J Pathol Oncol 2019;6(4):586-592

Copyright © 2019 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (